Illustration fo bees and flowers.

Shareholder Proposals

Shareholders of corporations have certain rights and opportunities to engage with a firm on strategic management and business impacts, including by participating in annual general meetings (AGM). A company’s management presents issues to be voted on in the proxy statement, and shareholders in certain markets have the right to submit proposals for inclusion on the ballot.


We have filed over 300 proposals as part of our active engagement strategy as a tactical tool to make progress on an underlying issue, for example if we reach an impasse or to elevate an issue before corporate management and the board. Companies will often engage with us and we are open to reaching an agreement, which results in a withdrawal of our proposal. If we cannot reach agreement, an eligible proposal is printed in the corporate proxy statement for a vote by all company shareholders.


In the United States, companies may sometimes choose to appeal to the U.S. Securities and Exchange Commission (SEC) to have proposals omitted from the ballot, arguing they fall within the grounds for exclusion. After SEC review, these may either be omitted, moved forward to a vote, or may otherwise be withdrawn if we reach an agreement.


We frequently collaborate with other investment firms, public pension funds and foundations. Below, we list under “lead filer” the filings in which we played the main role. Under “co-filer,” we list proposals where Domini played a supporting role.

For information on proposals filed in previous years, please contact us at info@domini.com.  

Shareholder Proposals listed by year of Annual General Meeting (AGM)

2021 | 2020

2021

Organization NameIssueResult / Vote Outcome
Beyond MeatPublish a sustainability reportWithdrawn
ChipotleBoard oversight of workforce equityWithdrawn
DisneyBoard oversight of workforce equityWithdrawn
Kohl’sFeasibility study on providing paid leaveOmitted by the SEC
NikeHuman rights in the cotton supply chain27% Vote
Walgreens Boots AllianceBonus DeferralWithdrawn
Lead Filer
Organization NameIssueResult / Vote Outcome
Bank of AmericaPolicy on financing oil and gas in ArcticWithdrawn
Regeneron PharmaceuticalsCOVID Treatment Access and PricingWithdrawn
Co-Filer

2020

Organization NameIssueResult / Vote Outcome
Alexion PharmaceuticalsPublish a sustainability reportWithdrawn
NucorLobbying report (tied to climate change denial)With Drawn
Lead Filer
Organization NameIssueResult / Vote Outcome
Walgreens Boots AllianceBonus deferralWithdrawn
Gilead SciencesBonus deferralWith drawn
VertexReport on incentive compensation risksWith drawn
Alphabet
Establish board committee on human rights risk oversight
16%
Co-Filer

2021 | 2020 |